TGFB1 and experimental autoimmune encephalomyelitis: Aside from its neurogenic and neuroprotective functions, TGF‐β has been recently investigated as remyelinating factor promoting oligodendrocyte maturation in experimental autoimmune encephalomyelitis (EAE) animal model.[166] The study provided new insights to understand the therapeutic mechanism by which systemic TGF‐β1 iss long‐standing used in the treatment of EAE and reveals the capacity of TGF‐β1 to contribute to neuronal networks regeneration after injury.